Comparing Eccentric Resistance Exercise in Prostate Cancer Survivors On and Off Hormone Therapy: A Pilot Study

PM and R

Volumn 1, Issue 11, 2009, Pages 1019-1024

  Hansen, Pamela A ^a   Dechet, Christopher B ^b   Porucznik, Christina A ^a   LaStayo, Paul C ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BICYCLE ERGOMETER; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; ECCENTRIC RESISTANCE EXERCISE; EXERCISE; FALL RISK; FEASIBILITY STUDY; HAMSTRING; HUMAN; KNEE; LOCOMOTION; MALE; MUSCLE FATIGUE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT POSITIONING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; SINGLE BLIND PROCEDURE; WALKING;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; FEASIBILITY STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE, SKELETAL; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RESISTANCE TRAINING; SURVIVORS; TREATMENT OUTCOME;

EID: 71949103430     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2009.09.016     Document Type: Article

References (35)

1. Cancer Facts and Figures 2007 (2007), American Cancer Society, Atlanta, GA
2. Hellerstedt B., and Pienta K. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52 (2002) 154-179
3. Jemal A., Tiwari R., Murray T., et al. Cancer statistics. CA Cancer J Clin 54 (2004) 8-29
4. Williams M., Hernandez J., and Thompson I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol 173 (2005) 1067-1071
5. Basaria S., Lieb J., Tang A., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56 (2002) 779-786
6. Bylow K., Dale W., Mustian K., et al. Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology 72 (2008) 422-427
7. Cassileth B., Soloway M., Vogelzang N., et al. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1 (1992) 323-330
8. Cleary R., Morrissey G., and Oster G. Health-related quality of life in patients with advanced prostate cancer: a multinational perspective. Qual Life Res 4 (1995) 207-220
9. Galvao D., Spry N., Taaffe D., et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int 102 (2008) 44-47
10. Galvao D., Taaffee D., Spry N., et al. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis (2008 Oct 14) [Epub]
11. Pickett M., Bruner D., Joseph A., et al. Prostate cancer elder alert: Living with treatment choices and outcomes. J Gerontol Nurs 26 (2000) 22-34
12. Smith M., Finelstein J., McGovern F., et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87 (2002) 599-603
13. Bylow K., Mohile S., Stadler W., and Dale W. Does androgen deprivation therapy accelerate the development of frailty in older men with prostate cancer?. A conceptual review. Cancer 110 (2007) 2604-2613
14. Galvao D., Nosaka K., Taaffe D., et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38 (2006) 2045-2052
15. Monga U., Garber S., Thornby J., et al. Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil 88 (2007) 1416-1422
16. Segal R., Reid R., Courneya K., et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol (2008 Dec 8) [Epub]
17. Segal R., Reid R., Courneya K., et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21 (2003) 1653-1659
18. Hortobagyi T. The positives of negatives: clinical implications of eccentric resistance exercise in old adults. J Gerontol A Biol Sci Med Sci 58 (2003) M417-M418
19. LaStayo P.C., Ewy G.A., Pierotti D.D., Johns R.K., and Lindstedt S. The positive effects of negative work: Increased muscle strength and decreased fall risk in a frail elderly population. J Gerontol A Biol Sci Med Sci 58 (2003) M419-M424
20. Lastayo P.C., Reich T.E., Urquhart M., Hoppeler H., and Lindstedt S.L. Chronic eccentric exercise: Improvements in muscle strength can occur with little demand for oxygen. Am J Physiol 276 (1999) R611-R615
21. LaStayo P.C., Pierotti D.J., Pifer J., Hoppeler H., and Lindstedt S.L. Eccentric ergometry: increases in locomotor muscle size and strength at low training intensities. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1282-R1288
22. Lindstedt S., LaStayo P., and Reich T. When active muscles lengthen: Properties and consequences of eccentric contractions. News Physiol Sci 16 (2001) 256-261
23. Dibble L.E., Hale T., Marcus R.L., Gerber J.P., and Lastayo P.C. The safety and feasibility of high-force eccentric resistance exercise in persons with Parkinson's disease. Arch Phys Med Rehabil 87 (2006) 1280-1282
24. Dibble L.E., Hale T.F., Marcus R.L., Droge J., Gerber J.P., and LaStayo P.C. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson's disease. Mov Disord 21 (2006) 1444-1452
25. Tracy B.L., Ivey F.M., Metter J.E., Fleg J.L., Siegel E.L., and Hurley B.F. A more efficient magnetic resonance imaging-based strategy for measuring quadriceps muscle volume. Med Sci Sports Exerc 35 (2003) 425-433
26. Bischoff H.A., Stähelin H.B., Monsch A.U., et al. Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. Age Ageing 32 (2003) 315-320
27. Enright P., McBurnie M., Bittner V., et al. The 6-min walk test: A quick measure of functional status in elderly adults. Chest 123 (2003) 325-327
28. Steffen T., Hacker T., and Mollinger L. Age and gender-related test performance in community-dwelling elderly people: Six-minute walk test, Berg balance scale, timed up and go test, and gait speeds. Phys Ther 82 (2002) 128-137
29. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales (1997), Center on Outcomes Research and Education, Northwestern University, Chicago, IL
30. Esper P., Mo F., Chodak G., Sinner M., Cella D., and Pienta K. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) instrument. Urology 50; (1997) 920-928
31. Cella D., Nichol M., Eton D., Nelson J., and Mulani P. Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy-Prostate: Results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health (2008 July 18) [Epub]
32. Yellen S. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
33. Cella D., Eton D., Lai J., Peterman A., and Merkel D. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 6 246 (2002) 547-561
34. Kidde J, Marcus R, Dibble L, Smith S, LaStayo P. Regional muscle and whole body composition factors related to an older individual's level of mobility: A review. Physiother Can [in press].
35. Fritz S., and Lusardi M. White paper: "Walking speed: The sixth vital sign". J Geriatr Phys Ther 32 (2009) 321-325